期刊文献+

三种检测铜绿假单胞菌AmpC酶方法的评价 被引量:2

To Evaluate the Three Methods Used in the Examination of AmpC Enzyme of Pseudomonas aeruginosa
下载PDF
导出
摘要 目的探讨一种简便易行,适用于临床微生物实验室常规开展检测AmpCβ内酰胺酶(简称AmpC酶)的方法。方法对临床分离的150株铜绿假单胞菌用表型筛选试验作AmpC酶测定,对AmpC酶阳性菌株同时进行氯唑西林双纸片协同试验、氟氯西林(FCC)双抑制剂扩散协同试验、PCR基因检测。用基因检测来评价比较三种测定方法的检出率及差异。结果表型筛选试验AmpC酶阳性37株同时进行氯唑西林双纸片协同试验、氟氯西林双抑制剂扩散协同试验、基因检测,检测出阳性株分别为15、14、11株,阳性率分别是40.54%(15/37)、37.84%(14/37)、29.73%(11/37)。表型筛选试验与后三种方法比较差异有统计学意义(P<0.01),后三种方法结果比较差异无统计学意义(P>0.05)。结论氯唑西林双纸片协同试验、氟氯西林双抑制剂扩散协同试验检测AmpC酶特异性较表型筛选试验高,且操作简便、结果可靠,适合临床实验室常规检测应用。 Objective To evaluate the suitability of using phenotype screening test, cloxacillin double-disk synergy test and flucloxacillin double dose resistance test in the detection of AmpC enzyme. Methods 150 clinical isolates of Pseudomonas aeruginosa were used in this study. PCR was used for the species identification. Results AmpC was detected in 37 isolates by phenotype screening test.The percentage of detection of AmpC by cloxacillin double-disk synergy test, flucloxacillin double dose resistance test, and genetic method was 40.54% (15/37), 37.83% (14/37), and 29.7% (11/37), respectively. Results from the phenotype screening test was significantly different from the other three methods (P〈0.01). The difference among cloxacillin double-disk synergy test, flucloxacillin double dose resistance test, and genetic method was not significant. Conclusion Cloxacillin double-disk synergy test and flucloxacillin double dose resistance test are more specific then the phenotype screening test. These two tests are easy to perform and are suitable for use in clinical microbiology laboratories
出处 《热带医学杂志》 CAS 2007年第5期470-472,共3页 Journal of Tropical Medicine
关键词 铜绿假单胞菌 AMPC酶 Pseudomonas aeruginosa AmpC
  • 相关文献

参考文献10

二级参考文献48

  • 1符惠群,谷海瀛,莫成锦,赖燕燕.临床分离细菌及耐药性3年监测情况报告[J].中国热带医学,2004,4(5):819-820. 被引量:4
  • 2吴蓉,府伟灵.重庆地区铜绿假单胞菌医院感染及耐药性分析[J].中华医院感染学杂志,2004,14(1):97-99. 被引量:143
  • 3蔡瑜娇,刘岚,刘昌林,刘昕,黄正根,高玉梅.儿童革兰阴性杆菌耐药状况及ampC基因的检测与分析[J].第三军医大学学报,2004,26(21):1957-1960. 被引量:5
  • 4马越,金少鸿.我国细菌耐药性监测研究的新特点[J].中华检验医学杂志,2005,28(4):344-348. 被引量:78
  • 5[3]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: ninth informational supplement[S]. NCCLS document M-100-S10, 2000. 19: 29-75.
  • 6[4]Coudron PE, Molaond ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center[J]. J Clin Mirobiol, 2000, 38: 1791-1796.
  • 7[12]Aralaw AY, Shibata N, Shibayama K, et al. Convenient test for screening metallo β-lactamases producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000, 38: 40-43.
  • 8Bush K, Jacoby GA, Medeiros AA. A functional classification for β-lactoamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995,39:1211-1214.
  • 9Pai H, Lyu S, Lee JH, et al. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol,1999, 37:1758-1763.
  • 10Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC Beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol, 2000,38:1791-1796.

共引文献413

同被引文献36

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部